Study to evaluate efficacy, safety, reactogenicity and immunogenicity study of the lyophilised formulation of human rotavirus (HRV) vaccine 444563 in healthy Japanese infants. - Trial 2015-001543-36
Access comprehensive clinical trial information for 2015-001543-36 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Biologicals and is currently status unknown. The study focuses on Healthy volunteers.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-001543-36
Trial Details
EU Clinical Trials Register • 2015-001543-36
Study to evaluate efficacy, safety, reactogenicity and immunogenicity study of the lyophilised formulation of human rotavirus (HRV) vaccine 444563 in healthy Japanese infants.
Study Focus
Sponsor & Location
GlaxoSmithKline Biologicals
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Occurrence of any RV GE leading to medical intervention and caused by the circulating wild-type RV strains.
ICD-10 Classifications
Healthy person accompanying sick person
Routine general health check-up of armed forces
Routine general health check-up of sports teams
Routine general health check-up of inhabitants of institutions
Data Source
EU Clinical Trials Register
2015-001543-36
Non-Device Trial